Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
480
datasets available to search
ShareScore release 0.7.1
Dataset results
480 results for “Hormone Receptors”
Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT03538171. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT04130152. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer
ClinicalTrials.gov study NCT05203445. IPD Sharing: YES. Countries: 1. Publications: 0.
Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33)
ClinicalTrials.gov study NCT06774807. IPD Sharing: YES. Countries: 1. Publications: 0.
Data from quantitative real-time PCR of corticotropin-releasing hormone and glucocorticoid receptor in the hippocampus and hypothalamus of rats subjected to midline fluid percussion injury or control sham surgery.
Open the record for dataset details and reuse information.
Data from: Stress hormone receptors change as range expansion progresses in house sparrows
Open the record for dataset details and reuse information.
Half-Dose Fulvestrant plus Anastrozole as a First-Line Treatment for Hormone Receptor-Positive Metastatic Breast Cancer: A Cost-Effectiveness Analysis
Open the record for dataset details and reuse information.
Data from: Thyroid hormone receptor beta mutations alter photoreceptor development and function in Danio rerio (zebrafish)
Open the record for dataset details and reuse information.
Supplementary data for: Reproductive deficits induced by prenatal anti-Mullerian hormone exposure require androgen receptor in kisspeptin cells
Open the record for dataset details and reuse information.
Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT03477396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer
ClinicalTrials.gov study NCT02291913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT00372996. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
ClinicalTrials.gov study NCT04504331. IPD Sharing: NO. Countries: 1. Publications: 0.
Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT04999540. IPD Sharing: NO. Countries: 0. Publications: 10.
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
ClinicalTrials.gov study NCT00754325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Loc
ClinicalTrials.gov study NCT00696072. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT02668666. IPD Sharing: NO. Countries: 1. Publications: 0.
Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov study NCT02283658. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer
ClinicalTrials.gov study NCT05558722. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemoth
ClinicalTrials.gov study NCT03270007. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.